
Journal of Medicinal Chemistry p. 1704 - 1711 (1994)
Update date:2022-08-05
Topics:
Gualtieri
Conti
Dei
Giovannoni
Nannucci
Romanelli
Scapecchi
Teodori
Fanfani
Ghelardini
Giotti
Bartolini
Previous studies have shown that (R)-(+)-hyoscyamine has analgesic activity as a consequence of increased ACh release following antagonism of central muscarinic autoreceptors. Since the enhancement of central cholinergic transmission could be beneficial for cognitive disorders, we manipulated (R)-(+)-hyoscyamine, synthesizing several derivatives of tropic and 2-phenylpropionic acids, with the aim of obtaining drugs which are able to increase ACh release and consequently to show analgesic and nootropic activities. The results showed that several new compounds are indeed potent analgesics (with an analgesic efficacy comparable to that of morphine) and that the most potent one ((±)-19, PG9) also has remarkable cognition- enhancing properties. Our study confirmed that the mechanism of action involves ACh release even if it is still unclear whether only muscarinic autoreceptors or, also, heteroreceptors are involved.
View MoreTaimai Sanluck Pharmaceutical Co.,Ltd
Contact:86-592-7662921
Address:8D,No.186,Huarong Road,Huli,Xiamen,China
Shanghai Xinda Pharmaceuticals Co., Ltd.
Contact:86-21-33692333-8008
Address:999 Linxian Road, Jinshan Industrial Park, Shanghai, China
Contact:+44 7958 511245
Address:PO Box 469, Manchester, UK
Purestar Chem Enterprise Co.,Ltd
website:http://www.purestarchem.com
Contact:05722157374
Address:no235.huanchengdong Rd
Nanjing distinctions Medical Technology Co., Ltd.(expird)
Contact:+86-15996203785 13914714059
Address:nanjing,jiangsu , China
Doi:10.1021/jo00954a018
(1973)Doi:10.1002/jhet.5570260525
(1989)Doi:10.1016/S0040-4039(00)76681-0
(1994)Doi:10.1021/jo00951a038
(1973)Doi:10.3184/030823408X320629
(2008)Doi:10.1021/acs.jmedchem.7b01492
(2019)